Eritrea: Eye Surgery for Over 250 Citizens in Golij Sub-zone
Dr. Merhawi Kiflom, Medical Director of the Golij Community Hospital, stated that the objective of the program was to provide citizens with access to eye care services, including surgical treatment, within their local areas.
Mr. Alem Zekarias, Head of the National Blindness Control Program, noted that while cataract surgeries were previously conducted in collaboration with foreign experts, the current program was implemented entirely through local capacity.
Dr. Eyob Beyene, one of the participating physicians, explained that cataracts often occur with age and are treatable and curable through timely surgical intervention.
Distributed by APO Group on behalf of Ministry of Information, Eritrea.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
18 hours ago
- Khaleej Times
UAE resident nearly dies after headache, loses part of skull in life-saving surgery
For 32-year-old Ananta Sahu, what began as a simple headache quickly turned into the most terrifying experience of his life. Over the course of a week, the pain became unbearable. He developed a high fever, stiffness in his neck, and could barely hold himself steady. Although he sensed something was wrong, he never imagined the situation was life-threatening. 'I had a terrible headache that wouldn't go away,' Ananta said. 'My neck hurt badly, and I had a constant fever. I couldn't even sit or walk properly. The pain kept getting worse, and I was scared I wouldn't survive.' As his condition rapidly worsened, Ananta was rushed to Ras Al Khaimah's Hospital's emergency department. Doctors immediately recognised a dangerous pattern of fever, headache, and neck stiffness — classic signs of a possible brain infection, which are often mistaken for the flu or muscle strain. An MRI scan revealed swelling in the cerebellum, the part of the brain responsible for balance and coordination. A follow-up scan confirmed their fears: Ananta had a brain abscess — a rare but serious infection that causes a build-up of pus in the brain. It not treated quickly, it can lead to stroke, meningitis, or even death. 'Brain abscesses are extremely dangerous and can progress quickly,' said Dr Tinku Jose Kurisinkal, consultant neurosurgeon at RAK Hospital. 'This patient's condition was critical because the infection had advanced rapidly. The challenge is that their symptoms often mimic less severe conditions. Fortunately, our team acted fast and didn't overlook the signs.' The neurosurgery team performed an emergency suboccipital craniectomy, a procedure where a part of the skull is temporarily removed to reach and drain the abscess. The surgery was successful, and Ananta's condition began improving within hours. Brain abscesses are rare, but they can develop when infections from the ear, nose, sinuses, or even teeth spread through the bloodstream to the brain. Because the early symptoms resemble migraines, flu, or neck pain, many patients dismiss them or rely on over-the-counter painkillers — often with dangerous consequences. Dr Tinku warns that if someone has a fever along with persistent headache, vomiting, or neck pain, it should never be taken lightly. 'Quick medical checks, especially scans, can help catch these problems early and save lives.' Dr Raza Siddiqui, executive director, RAK Hospital said the case was a reminder of how powerful timely action can be. 'Many people delay seeking care or treat symptoms at home. But in cases like these, even a small delay could be fatal. This story shows how important it is to act early and trust expert care.' Now fully recovered, the RAK resident is back on his feet and deeply grateful for a second chance at lufe. His message to others is simple but powerful: 'Don't ignore pain. Listen to your body. And when in doubt, go to a doctor, before it's too late.'
Zawya
2 days ago
- Zawya
AstraZeneca enters rare disease care in South Africa
AstraZeneca announced its entrance into rare disease care in South Africa at a launch event held at the Nelson Mandela Children's Hospital in Johannesburg. Its rare disease portfolio will bring treatments for complex conditions such as neurofibromatosis type 1 (NF1), paroxysmal nocturnal hemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS), and myasthenia gravis. The event included a panel discussion with experts from fields such as neuro-oncology, neurology, plastic surgery, and genetics. Panellists highlighted the vital need for coordinated, specialist-driven care and robust collaboration across public and private sectors to ensure that patients receive integrated support at every stage of their journey. Dr Nkuli Boikhutso, CEO of Nelson Mandela Children's Hospital, stated: 'We are honoured to be the site of this important milestone. "AstraZeneca's commitment to introducing new treatments for rare diseases offers hope for our young patients and aligns with our vision to provide world-class, specialised care for all children, regardless of their background.' Rare diseases Around the world, more than 400 million people are affected by over 10,000 known rare diseases, yet the vast majority of these conditions have no approved treatments. For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or difficult treatment options. AstraZeneca is dedicated to transforming this landscape by introducing advanced therapies, supporting earlier and more accurate diagnoses, and fostering multidisciplinary collaboration. 'AstraZeneca's entry into the rare disease space in South Africa is both a proud and hopeful moment for us,' said Deepak Arora, African cluster country president at AstraZeneca. 'Building on decades of pioneering rare disease science, we are committed to expanding access to transformational medicines for conditions such as NF1, PNH. 'This marks a significant milestone in our mission to improve the lives of patients living with rare diseases, especially children who have had very few options until now.' AstraZeneca's rare disease strategy in Africa is anchored in three key priorities: accelerating access to vital medicines, driving innovation through research and development, and expanding its global reach to make meaningful change. All rights reserved. © 2022. Provided by SyndiGate Media Inc. (
Zawya
4 days ago
- Zawya
KFSHRC advances robotic surgery with a successful Ivor Lewis Esophagectomy
King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh successfully performed a robotic Ivor Lewis esophagectomy, the first of its kind in the Middle East, on a 46-year-old male diagnosed with gastroesophageal junction adenocarcinoma, a type of cancer located near the area where the esophagus meets the stomach. The patient regained mobility within two days of surgery, began oral intake by day five, and was discharged within ten days. This outcome demonstrates the effectiveness of the robotic approach in reducing pain, minimizing complications, and accelerating recovery compared to conventional surgery. The procedure was led by Dr. Khalid Aldaghri, Consultant in bariatric, upper gastrointestinal, and robotic surgery at KFSHRC. Utilizing the Ivor Lewis technique, a complex and technically demanding procedure involving two phases. The abdominal phase involved stomach mobilization and creation of a gastric conduit. This was followed by the thoracic phase, in which the diseased esophagus was resected and the conduit is robotically connected within the chest. Precision in the robotic system enabled surgeons to reach deep anatomical areas without large incisions, enhancing safety, reducing risks, and improving outcomes in one of the most complex cancer surgeries. Close collaboration among surgical, anesthesia, nursing, and technical teams was key to the procedure's success. All teams worked synchronously across every stage, from pre-op planning to post-op recovery. This approach reflects KFSHRC's multidisciplinary model of care, designed to improve patient outcomes and boost clinical efficiency. With its advanced features, the robotic surgery significantly enhanced the safety and accuracy of the esophagectomy by offering three-dimensional high-definition visualization, stable instrument control, and superior access within confined anatomical spaces. These capabilities enabled more precise dissection, better preservation of surrounding structures such as nerves and vessels and reduced intraoperative risks. The technology also made it physically easier for the surgeon to operate over an extended period. As a medical milestone, the success of this procedure opens the door for broader applications of robotic surgery at KFSHRC. It enables more patients to benefit from advanced surgical techniques and reinforces the institution's commitment to clinical innovation, safety, and effective alternatives to traditional surgical approaches. It is noteworthy that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for 2025. It was also recognized as the most valuable healthcare brand in the Kingdom and the Middle East by Brand Finance in 2024 and was listed among the World's Best Smart Hospitals by Newsweek for 2025.
